New drug cocktail aims to save bladders in cancer fight
Disease control
Recruiting now
This phase 2 trial tests two drugs, enfortumab vedotin and pembrolizumab, in 47 people with muscle-invasive bladder cancer. The goal is to see if the combination can eliminate the cancer so patients can keep their bladder instead of having it surgically removed. After three cycle…
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC